September 22, 2014 7:02 PM ET

Pharmaceuticals

Company Overview of KAI Pharmaceuticals, Inc.

Executive Profile

Steven P. James

AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 6 different industries.

See Board Relationships
----

Background

Mr. Steven P. James, also known as Steve, served as the President and Founding Chief Executive Officer of Labrys Biologics, Inc., a private venture-backed start-up developing a monoclonal antibody against neuropeptide calcitonin gene related peptide (CGRP) for the prevention of chronic migraine, until it was acquired by Teva Pharmaceuticals in July 2014. Mr. James served as President and Chief Executive Officer of KAI Pharmaceuticals, Inc. from October 15, 2004 to 2012. ...

Corporate Headquarters

270 Littlefield Avenue
South San Francisco, California 94080-6924

United States

Phone: 650-244-1100
Fax: 650-244-1199

Board Members Memberships

Chief Executive Officer, President and Executive Director
Director
2014-Present
Lead Independent Director and Chairman of Compensation Committee

Education

Bachelor's Degree
Brown University
Master's Degree
J.L. Kellogg School of Management, Northwestern University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Actavis plc
--
Robert L. Parkinson Jr.Chairman, Chief Executive Officer and President
Baxter International Inc.
$1.5M
Erez Vigodman Chief Executive Officer, President, Director, Member of Audit Committee and Member of Finance & Invesment Committee
Teva Pharmaceutical Industries Limited
--
Lars Rebien Sørensen Chief Executive Officer
Novo Nordisk A/S
$15.2M
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.5M
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KAI Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.